UY29778A1 - Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen. - Google Patents

Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen.

Info

Publication number
UY29778A1
UY29778A1 UY29778A UY29778A UY29778A1 UY 29778 A1 UY29778 A1 UY 29778A1 UY 29778 A UY29778 A UY 29778A UY 29778 A UY29778 A UY 29778A UY 29778 A1 UY29778 A1 UY 29778A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
compositions containing
agomelatin
noradrenaline
new association
Prior art date
Application number
UY29778A
Other languages
English (en)
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY29778A1 publication Critical patent/UY29778A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen.
UY29778A 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen. UY29778A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY29778A1 true UY29778A1 (es) 2006-10-31

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29778A UY29778A1 (es) 2005-09-09 2006-08-31 Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen.

Country Status (39)

Country Link
US (1) US7622505B2 (es)
EP (1) EP1769798B1 (es)
JP (2) JP5395998B2 (es)
KR (1) KR100863384B1 (es)
CN (1) CN1927205A (es)
AP (1) AP2615A (es)
AR (1) AR056056A1 (es)
AT (1) ATE404205T1 (es)
AU (1) AU2006209368B2 (es)
BR (1) BRPI0603759A (es)
CA (1) CA2558782C (es)
CY (1) CY1108319T1 (es)
DE (1) DE602006002210D1 (es)
DK (1) DK1769798T3 (es)
EA (1) EA011650B1 (es)
ES (1) ES2313590T3 (es)
FR (1) FR2890564B1 (es)
GE (1) GEP20094742B (es)
GT (1) GT200600408A (es)
HR (1) HRP20080535T3 (es)
JO (1) JO2521B1 (es)
MA (1) MA28505B1 (es)
ME (2) ME02758B (es)
MX (1) MXPA06010157A (es)
MY (1) MY142260A (es)
NO (1) NO338029B1 (es)
NZ (1) NZ549725A (es)
PE (1) PE20070429A1 (es)
PL (1) PL1769798T3 (es)
PT (1) PT1769798E (es)
RS (1) RS50631B (es)
SA (1) SA06270308B1 (es)
SG (1) SG131030A1 (es)
SI (1) SI1769798T1 (es)
TW (1) TWI324513B (es)
UA (1) UA83542C2 (es)
UY (1) UY29778A1 (es)
WO (1) WO2007028904A1 (es)
ZA (1) ZA200607562B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008247805A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
US20080280991A1 (en) * 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
PL372393A1 (en) * 2002-02-26 2005-07-25 Ortho-Mcneil Pharmaceutical Inc. Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
CN1878546A (zh) * 2003-09-12 2006-12-13 沃纳-兰伯特公司 治疗抑郁症和焦虑症的包括α－2δ配体和SSRI和/或SNRI的联用药物

Also Published As

Publication number Publication date
EP1769798A1 (fr) 2007-04-04
US20070060654A1 (en) 2007-03-15
NO338029B1 (no) 2016-07-25
JP2007077147A (ja) 2007-03-29
GT200600408A (es) 2007-05-21
DK1769798T3 (da) 2008-11-24
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
EP1769798B1 (fr) 2008-08-13
WO2007028904A1 (fr) 2007-03-15
AP2615A (en) 2013-03-14
SA06270308B1 (ar) 2011-10-08
AP2008004378A0 (en) 2008-04-30
AR056056A1 (es) 2007-09-12
TWI324513B (en) 2010-05-11
EA200601410A1 (ru) 2007-04-27
CN1927205A (zh) 2007-03-14
NO20064048L (no) 2007-03-12
TW200744570A (en) 2007-12-16
DE602006002210D1 (de) 2008-09-25
CA2558782A1 (fr) 2007-03-09
ME02758B (me) 2010-06-30
CA2558782C (fr) 2012-05-15
AU2006209368A1 (en) 2007-03-29
ATE404205T1 (de) 2008-08-15
SI1769798T1 (sl) 2008-12-31
PT1769798E (pt) 2008-09-18
EA011650B1 (ru) 2009-04-28
FR2890564A1 (fr) 2007-03-16
GEP20094742B (en) 2009-07-27
NZ549725A (en) 2008-03-28
SG131030A1 (en) 2007-04-26
US7622505B2 (en) 2009-11-24
CY1108319T1 (el) 2014-02-12
UA83542C2 (uk) 2008-07-25
RS50631B (sr) 2010-06-30
JP5395998B2 (ja) 2014-01-22
PL1769798T3 (pl) 2008-12-31
MA28505B1 (fr) 2007-04-03
ES2313590T3 (es) 2009-03-01
FR2890564B1 (fr) 2007-10-19
PE20070429A1 (es) 2007-06-02
JO2521B1 (en) 2010-03-17
KR20070029606A (ko) 2007-03-14
MXPA06010157A (es) 2007-03-08
KR100863384B1 (ko) 2008-10-13
HRP20080535T3 (en) 2008-12-31
ZA200607562B (en) 2008-05-28
JP2011088919A (ja) 2011-05-06
BRPI0603759A (pt) 2007-05-15
AU2006209368B2 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
DOP2019000185A (es) Una formulación sólida de dosificación farmacéutica
NO20080023L (no) Magnetoreologisk vaeske
CL2007001325A1 (es) Compuestos derivados de biciclos, inhibidores de cept; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, entre otras enfermedades.
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
NO20082048L (no) Ny formulering
NO20040828L (no) Instrumentert pakning.
CY1111530T1 (el) Κρυσταλλικες μορφες υδροχλωριδιου (-)-(1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλοπροπυλο)-φαινολης για τη χρηση σαν ενεργο συστατικο σε φαρμακευτικες συνθεσεις
DK1858491T3 (da) Sublingual overtrukket tablet
CR8418A (es) Biaril sulfonamidas y metodos para su uso
BRPI0606118A2 (pt) uma sìntese assimétrica de (s) - (+) -3- (aminometil) -5- ácido metilhexanóico
HN2006015130A (es) Asociacion entre la ferroquina y un derivado de artemisina para el tratamiento del paludismo
DE602005010780D1 (de) Gestreckte Ausführung eines Bremssattels.
UY27610A1 (es) Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
ES2571834T3 (es) Alquilsulfonamida quinolinas
UY29778A1 (es) Nueva asociación entre la agomelatina y un inhibidor de recaptura de noradrenalina y composiciones farmacéuticas que la contienen.
PA8571901A1 (es) Nueva composicion farmaceutica
CR8813A (es) Nueva asociacion de un inhibidor de la corriente sinusual l1 y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
FR2912057B1 (fr) Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
CR10579A (es) Composicion farmaceutica que contiene en asociacion saredutant y un inhibidor selectivo de la recaptacion de serotonina o un inhibidor de la recaptacion de serotonina/norepinefrina
FR2891028B1 (fr) Source de pression de type compresseur a electro-aimant.
UY29776A1 (es) Nueva asociación entre la agomelatina y un agente timoregulador y composiciones farmacéuticas que la contienen
TW200744571A (en) Combination of β3 receptor agonist and of monoamine reuptake inhibitors, pharmaceutical composition containing it and therapeutic use thereof
ES1051030Y (es) Embalaje expositor para herramienta.
UY27785A1 (es) Nueva composición farmacéutica

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20171115